Lionheart Health, Inc., operator of Lionheart Longevity & Wellness Clinics, will present its regenerative medicine technologies at the 2025 Octane Medical Innovation Forum on October 28-29 in Irvine, California. The forum, which focuses on "The Science of Longevity," brings together medical industry experts, entrepreneurs, investors, and thought leaders for two days of learning and innovation. More information about the event is available at https://www.octane-oc.org/event/omif/agenda.
Executive Chairman and co-CEO Howard Leonhardt will present the company's first-in-class technology platform that uses patented bioelectric signaling sequences to trigger the release of regeneration-promoting proteins. The technology controls expression of klotho, a protein identified as crucial for aging management, and regulates stem cell recruitment, proliferation, and differentiation on demand. This approach represents a significant advancement in regenerative aesthetics and healthspan longevity technologies.
The company's business model involves licensing its patented technology platform to clinics worldwide through exclusive territory agreements. Currently operating one clinic in Newport Beach, California, with seven additional licensed locations, Lionheart Health aims to establish 124 licensed clinics within the next five years. This expansion strategy demonstrates the commercial viability and growing demand for regenerative medicine technologies.
Lionheart Health's technological achievements have garnered significant industry recognition. The company was named a top 40 semi-finalist in the XPRIZE Healthspan Competition among 600 entries, focusing on improving muscle health, brain health, and immunity health with the goal of increasing healthy living years by two decades. Recent accolades include Medtech Outlook Magazine's Top Micro Stimulator Implant Development of 2025 award and finalist positions in both the Orange County Business Journal's Innovator of the Year Award and the Octane High Tech Awards' Medical Innovation category.
The company's most ambitious project involves developing a whole-body regeneration chamber described as a "womb for adults." Current prototypes utilize non-invasive technologies, with future versions planned to incorporate advanced robotics, artificial intelligence, and implantable pump and stimulation technologies for internal organ regeneration. This development represents a potential paradigm shift in regenerative medicine approaches.
Lionheart Health recently announced a partnership with CoreViva for AI-enhanced MRI diagnostics and maintains long-standing relationships with University Lab Partners and the UCI Beall Applied Innovation Center Prototyping Lab. The company has received multiple UCI Capstone Grants, including support for its Brain Band bioelectric stimulation technology platform for brain health. Additional company information can be found at http://www.lionhearthealthstim.com and http://www.lionheartlongevity.com.
The presentation at the Octane Medical Innovation Forum signifies the growing importance of regenerative medicine in addressing aging-related health challenges. As populations worldwide face increasing longevity with corresponding healthspan concerns, technologies that can potentially regenerate organs and extend healthy living years represent a critical frontier in medical science. The forum provides a platform for sharing these innovations with industry leaders who can help accelerate their development and implementation.
Lionheart Health's approach to controlled protein expression and stem cell management through bioelectric signaling offers a novel methodology distinct from pharmaceutical or genetic interventions. The technology's potential applications in both medical aesthetics and serious health conditions demonstrate the broad relevance of regenerative medicine advancements. As the company continues to expand its clinic network and develop more advanced regeneration technologies, its progress will be closely watched by medical professionals, investors, and patients seeking innovative solutions for age-related health decline.
